<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Primary pyomyositis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Primary pyomyositis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Primary pyomyositis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Larry M Baddour, MD, FIDSA, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anuwat Keerasuntornpong, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sandra Nelson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Primary pyomyositis is a purulent infection of skeletal muscle that arises from presumed or confirmed hematogenous infection, whereas secondary pyomyositis occurs from localized penetrating trauma or contiguous spread to the muscle [<a href="#rid1">1</a>]. Primary infections usually have a subacute onset and most commonly affect the extremities or muscles of the hip and pelvis.</p><p>The clinical approach to primary pyomyositis will be reviewed here, except for psoas abscess, which is discussed elsewhere (see  <a class="medical medical_review" href="/d/html/7652.html" rel="external">"Psoas abscess"</a>). Secondary pyomyositis and other soft tissue infections, such as clostridial myonecrosis and necrotizing fasciitis, are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/7672.html" rel="external">"Clostridial myonecrosis"</a> and  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections"</a>.)</p><p class="headingAnchor" id="H251333174"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Pyomyositis is a purulent infection of skeletal muscle, often with abscess formation [<a href="#rid1">1</a>]. It is classified as either primary or secondary:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary pyomyositis</strong> – Pyomyositis is classified as primary if it is presumed to have occurred via hematogenous spread from prior transient bacteremia or concurrent bacteremia [<a href="#rid2">2</a>]. The bacteremia may be idiopathic or secondary to a remote site of infection.</p><p></p><p class="bulletIndent1">Traditionally, primary pyomyositis was termed "tropical myositis" or "tropical pyomyositis" because it was reported most frequently in tropical regions of the world. However, new terminology has emerged because the disease can occur in any climate [<a href="#rid3">3-10</a>]. The following terms are now used interchangeably: primary pyomyositis, tropical pyomyositis, tropical myositis, infectious pyomyositis, pyogenic myositis, suppurative myositis, myositis purulenta tropica, myositis tropicans, epidemic abscess, pyomyositis, and bacterial pyomyositis.</p><p></p><p class="bulletIndent1">For the purposes of this topic, we utilize the term "primary pyomyositis," regardless of geography. The only differences between tropical pyomyositis and nontropical pyomyositis are the geography and risk factors for infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Secondary pyomyositis</strong> – Secondary pyomyositis is due to localized penetrating trauma (eg, puncture wound) or contiguous spread to muscle from an adjacent infection (eg, appendicitis). Secondary pyomyositis is discussed in separate topics. (See  <a class="medical medical_review" href="/d/html/7661.html" rel="external">"Infectious complications of puncture wounds", section on 'Evaluation'</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H95302484"><span class="h2">Geographic prevalence</span><span class="headingEndMark"> — </span>Traditionally, primary pyomyositis was mostly reported in the tropical regions of Asia, Africa, Oceania, and the Caribbean islands [<a href="#rid2">2,10,11</a>]. Data suggest that it is responsible for 1 to 4 percent of all surgical admissions in some tropical countries [<a href="#rid5">5,12-14</a>].</p><p>Observational data suggest an increasing prevalence in temperate climates, and primary pyomyositis is estimated to account for up to 0.1 percent of pediatric admissions in these regions [<a href="#rid7">7,8,15-18</a>]. Most cases in temperate locales occur during warmer months or rainy seasons, and countries with tropical and temperate regions have higher rates of infection in the tropical regions [<a href="#rid5">5,15,19-21</a>].</p><p class="headingAnchor" id="H636158476"><span class="h2">Risk factors</span></p><p class="headingAnchor" id="H1137842117"><span class="h3">Young age</span><span class="headingEndMark"> — </span>Healthy children older than two years of age and young adults compose the majority of cases in tropical regions [<a href="#rid2">2,5,10-14</a>]. In the United States, the highest incidence of hospitalization for primary pyomyositis occurs in children, especially those between the ages of 5 and 9 years [<a href="#rid3">3,8,14,17</a>].</p><p class="headingAnchor" id="H1297876308"><span class="h3">Exercise or muscle trauma</span><span class="headingEndMark"> — </span>In case series, 20 to 60 percent of individuals with primary pyomyositis report prior vigorous exercise or nonpenetrating muscle trauma, such as a bruise or strain [<a href="#rid5">5,8,10,14,15,17,19,22-32</a>].</p><p class="headingAnchor" id="H3964129890"><span class="h3">Immunocompromising condition</span><span class="headingEndMark"> — </span>Patients with primary pyomyositis often have an underlying immunocompromising condition.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>HIV infection</strong> – Human immunodeficiency virus (HIV) is a particularly important risk factor [<a href="#rid3">3,6,8,14,33-39</a>]. In a systematic review and meta-analysis of 12 studies involving over 500 individuals with pyomyositis in Africa, the only risk factors identified were HIV infection (odds ratio [OR] 4.8; 95% CI, 1.7-13.9) and acquired immunodeficiency syndrome (AIDS) (OR 6.1; 95% CI, 2.8-13.2) [<a href="#rid39">39</a>]. In a review of all pyomyositis hospitalizations in the United States between 2002 and 2014, HIV infection was the strongest risk factor identified (OR, 4.8; 95% CI, 4.3-5.4) [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other immunocompromising conditions</strong> – Numerous other conditions with some level of immunocompromise have been identified in case series, including diabetes mellitus, injection drug use disorder, pregnancy, hematologic malignancy, rheumatologic conditions (eg, Felty syndrome, systemic lupus erythematosus), solid organ transplant, biologic therapies (eg, <a class="drug drug_general" data-topicid="91388" href="/d/drug information/91388.html" rel="external">obinutuzumab</a>, certolizumab), malnutrition, cirrhosis, and renal disease [<a href="#rid2">2,3,15,22,30,32,33,40-69</a>].</p><p></p><p class="headingAnchor" id="H2263870399"><span class="h3">Recent infection</span><span class="headingEndMark"> — </span>Recent bloodstream infection and concurrent infections (eg, pneumonia, toxocariasis, varicella, tuberculosis) have been associated with pyomyositis [<a href="#rid17">17,32,39,40</a>].</p><p class="headingAnchor" id="H8"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>The most common cause of primary pyomyositis is <em>Staphylococcus aureus</em> (<em>S. aureus</em>), including methicillin-resistant <em>S. aureus </em>(MRSA). <em>S. aureus</em> causes approximately 90 percent of tropical cases and 75 percent of cases in temperate regions [<a href="#rid2">2,3,5,8,10,22,39,41-43,70-74</a>].</p><p>Group A <em>Streptococcus</em> (GAS; ie, <em>S. pyogenes</em>) is more common in healthy children and young adults than in other patient populations; observational data suggest that 20 to 25 percent of infections in children are due to GAS [<a href="#rid3">3,8,14,15,62</a>].</p><p>Other less common microbial causes include non-GAS streptococci, gram-negative bacilli (eg, <em>Escherichia coli</em>,<em> Klebsiella </em>spp, <em>Pseudomonas </em>spp), and anaerobes [<a href="#rid2">2-4,14,22,43,45,46,57,62,63,75-79</a>]. Reports suggest that these pathogens occur more frequently in individuals who have serious comorbidities, such as an immunocompromising condition or injection drug use disorder. Polymicrobial infections have been reported as well.</p><p>Rarely, pyomyositis may be caused by atypical pathogens such as <em>Neisseria gonorrhoeae</em>,<em> Neisseria meningitidis</em>,<em> </em>mycobacteria, and <em>Candida </em>spp [<a href="#rid3">3,14,55,58,61,77,80-86</a>].</p><p class="headingAnchor" id="H9"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Patients with pyomyositis typically present with fever and pain localized to a single muscle, although multifocal infection occasionally occurs.</p><p class="headingAnchor" id="H2141071523"><span class="h2">Course of illness</span><span class="headingEndMark"> — </span>Onset of symptoms is typically gradual, beginning with dull localized pain that becomes more severe over one to two weeks.</p><p>The illness has been described as evolving over three stages that represent progression of disease from diffuse inflammation to focal abscess to sepsis; over 95 percent of patients present with stage 2 or 3 disease [<a href="#rid2">2,15,70</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 1</strong> – Patients in stage 1 experience insidious onset of dull, crampy, localized muscle pain and swelling. Low-grade fever and mild leukocytosis may be present. Palpation may reveal induration or a "woody" texture of the affected muscle, but fluctuance is not present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 2</strong> – Ten to 21 days after the initial onset of symptoms, stage 2 begins. Patients with stage 2 disease have fever (&gt;100.5°F/38°C), a tender muscle mass often described as either fluctuant or firm and woody, and mildly erythematous and edematous overlying skin. Marked leukocytosis is usually present. More than 90 percent of patients with primary pyomyositis present at this stage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 3</strong> – This stage is characterized by systemic toxicity with high fever (eg, temperature &gt;101.3°F/38.5°C, hypotension, tachycardia) and an exquisitely tender and fluctuant muscle mass with erythema and edema.</p><p></p><p>In clinical practice, the stages may overlap, particularly for pyomyositis of the hip and pelvis [<a href="#rid17">17,21,87</a>].</p><p class="headingAnchor" id="H1551505370"><span class="h2">Anatomic sites of infection</span><span class="headingEndMark"> — </span>Primary pyomyositis can occur in any skeletal muscle. Careful clinical history and physical examination are necessary to localize symptoms and signs to the involved muscle(s), particularly for infections in young children or involving nonextremity muscles.</p><p>Most patients have only a single muscle or muscle group involved. Multifocal infection has been reported in up to 20 percent of cases [<a href="#rid3">3,15,88</a>].</p><p class="headingAnchor" id="H2789997456"><span class="h3">Extremity muscles</span><span class="headingEndMark"> — </span>Patients with pyomyositis of an extremity typically present with pain and tenderness at the site of the affected muscle group, and they may or may not have focal signs of inflammation (eg, induration, fluctuance)  (<a class="graphic graphic_picture graphicRef140857" href="/d/graphic/140857.html" rel="external">picture 1</a>).</p><p>In adults, an extremity is the most common site of infection. The lower extremity is affected more often than the upper, and hands and feet are rarely involved [<a href="#rid3">3,4,14,15,64</a>]. An understanding of the anatomy of the extremity muscles can help to localize the site of infection  (<a class="graphic graphic_figure graphicRef98221" href="/d/graphic/98221.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef98222" href="/d/graphic/98222.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef98223" href="/d/graphic/98223.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef98224" href="/d/graphic/98224.html" rel="external">figure 4</a> and <a class="graphic graphic_figure graphicRef58376" href="/d/graphic/58376.html" rel="external">figure 5</a>).</p><p>In patients without signs of inflammation (ie, stage 1), the infection can be easily confused with more benign conditions, such as muscle strain. As the infection progresses, symptoms and signs of infection become more obvious.</p><p class="headingAnchor" id="H2281527044"><span class="h3">Muscles of the hip and pelvis</span><span class="headingEndMark"> — </span>The muscles of the hip and pelvis are commonly reported sites of infection, especially in children [<a href="#rid2">2-4,7,14,15,17,21,64-69,87</a>]. A notable exception is the muscles of the pelvic floor which seem to be spared.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psoas and iliacus muscles (ie, iliopsoas muscles)</strong> – Patients with iliopsoas infection present with subacute onset of back, flank, or lower abdominal pain that worsens with passive extension of the hip (ie, the "psoas sign") and improves with hip flexion. Most patients prefer to lie still with their hip flexed. The muscle itself is rarely palpable on exam.</p><p></p><p class="bulletIndent1">Most patients with iliopsoas infection have concomitant vertebral osteomyelitis and/or discitis. It is often unclear whether the iliopsoas or the vertebral infection came first [<a href="#rid4">4,15,64,89,90</a>].</p><p></p><p class="bulletIndent1">The iliopsoas muscles are among the most common sites of primary pyomyositis. Further detail regarding psoas abscesses is found elsewhere, and the anatomy of the iliopsoas muscles is depicted in the figures  (<a class="graphic graphic_figure graphicRef98221" href="/d/graphic/98221.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef98223" href="/d/graphic/98223.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef99546" href="/d/graphic/99546.html" rel="external">figure 6</a>). (See  <a class="medical medical_review" href="/d/html/7652.html" rel="external">"Psoas abscess"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gluteus muscles</strong> – Patients with infections of the gluteus muscles have localized tenderness of the buttocks on palpation. During stage 1 of infection, misdiagnosis as muscle strain or bruising is common, but induration and/or fluctuance are palpable in stages 2 and 3.</p><p></p><p class="bulletIndent1">The anatomy of the gluteal muscles can be seen in the figures  (<a class="graphic graphic_figure graphicRef98222" href="/d/graphic/98222.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef98224" href="/d/graphic/98224.html" rel="external">figure 4</a> and <a class="graphic graphic_figure graphicRef70825" href="/d/graphic/70825.html" rel="external">figure 7</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Deep muscles of the hip and pelvis</strong> – The small, deep muscles of the hip and pelvis (eg, piriformis, obturators, quadratus femoris) are commonly reported sites of infection, especially in children [<a href="#rid2">2,3,17,64-69,87,90,91</a>]. The pelvic floor muscles are typically spared.</p><p></p><p class="bulletIndent1">Adult patients typically complain of hip or groin pain with movement. The type of movement (eg, flexion, extension, abduction, adduction) that elicits pain depends on the specific muscle involved; this finding is in contrast to septic arthritis of the hip which causes pain with any movement of the joint [<a href="#rid87">87</a>]. Deep palpation of the hip and buttocks may reveal tenderness. In some cases, rectal examination may reveal tenderness on palpation of the involved muscle.</p><p></p><p class="bulletIndent1">Young children with pelvic pyomyositis often cannot verbalize the location of their pain and often present with irritability. Examination of children often reveals a limp or inability to bear weight as well as decreased range of motion of the hip joint [<a href="#rid17">17,87</a>]. The correct diagnosis is often delayed in children; case series suggest that the correct diagnosis is made on admission in zero to 25 percent of childhood cases [<a href="#rid15">15,17,92</a>].</p><p></p><p class="bulletIndent1">Pregnant individuals are particularly prone to infection of the pyriformis muscle. The primary complaint in such patients is low back pain with or without unilateral leg pain [<a href="#rid64">64-69</a>]. The diagnosis is often delayed due to the increased frequency of noninfectious causes of musculoskeletal pain during pregnancy, as discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/427.html" rel="external">"Maternal adaptations to pregnancy: Musculoskeletal changes and pain"</a>.)</p><p></p><p>The anatomy of deep hip and pelvis muscles is depicted in the figure  (<a class="graphic graphic_figure graphicRef98484" href="/d/graphic/98484.html" rel="external">figure 8</a>).</p><p class="headingAnchor" id="H504939265"><span class="h3">Other sites of infection</span><span class="headingEndMark"> — </span>Less common anatomic sites of infection include the shoulder, abdominal wall, latissimus dorsi, and sternocleidomastoid muscles [<a href="#rid4">4,21,64,93-95</a>].</p><p class="headingAnchor" id="H4173818876"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>Laboratory findings are nonspecific.</p><p>Leukocytosis with a left shift is common, especially in advanced stages of infection. Inflammatory markers (eg, erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]) are often elevated; in one series of 47 children with hip or pelvic pyomyositis, over 90 percent of tested patients had elevated ESR and CRP with a mean ESR of 68 mm/hour (normal ≤31 mm/hour) and CRP of 103 mg/L (normal &lt;10 mg/L) [<a href="#rid17">17</a>]. Procalcitonin has also been reported to be elevated in case series.</p><p>Counterintuitively, serum creatine kinase levels are usually normal in all stages of illness, but elevations occasionally occur in the late stages [<a href="#rid3">3,4,15,17</a>].</p><p class="headingAnchor" id="H2559503514"><span class="h1">SPECIAL POPULATIONS</span><span class="headingEndMark"> — </span>While pyomyositis can occur in any individual, children and individuals who are pregnant appear to be particularly prone.</p><p class="headingAnchor" id="H1330404966"><span class="h2">Children</span><span class="headingEndMark"> — </span>Children older than two years of age have higher rates of pyomyositis than adults. Presentations are often different in children because children often can't localize their pain and because the muscles of the deep pelvis are disproportionately affected in children, as discussed above. (See <a class="local">'Extremity muscles'</a> above and <a class="local">'Muscles of the hip and pelvis'</a> above.)</p><p>Pyomyositis symptoms in children have been incorrectly attributed to multiple conditions, including muscle strain, septic arthritis, appendicitis, and hip pathology, as discussed elsewhere. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H4213052778"><span class="h2">Pregnant individuals</span><span class="headingEndMark"> — </span>Pyomyositis has been reported in pregnant individuals, and the pyriformis muscle is particularly affected in this population. The presentation is often nonspecific, and the diagnosis is often delayed due to the many causes of localized back and buttock pain during pregnancy, as discussed above. (See <a class="local">'Muscles of the hip and pelvis'</a> above.)</p><p class="headingAnchor" id="H3170040470"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Most cases of primary pyomyositis are isolated only to the muscle. However, certain complications have been described:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toxic shock syndrome</strong> – In patients with pyomyositis due to group A <em>Streptococcus </em>(GAS; ie, <em>S. pyogenes</em>) and other beta-hemolytic streptococci,<em> </em>toxic shock syndrome (TSS) can occur and is associated with poorer outcomes<em> </em>[<a href="#rid14">14,32,96,97</a>]<em>. </em>Reports of TSS due to staphylococcal pyomyositis are scarce. Diagnosis of TSS includes refractory hypotension and multiorgan system involvement and is described in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/3162.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/3162.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis", section on 'Diagnostic criteria'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Septic arthritis and osteomyelitis</strong> – The most frequently reported complication of primary pyomyositis is septic arthritis or osteomyelitis from contiguous spread of infection to an adjacent joint or bone. These complications are particularly common in individuals with pyomyositis of the hip and pelvis [<a href="#rid2">2,11,17,21,36</a>].</p><p></p><p class="bulletIndent1">Joint or bone pain is the primary complaint in these patients, but their pain may be difficult to differentiate from pain caused by the adjacent muscle infection. These conditions are discussed in detail elsewhere. (See <a class="local">'Additional tests'</a> below and  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Compartment syndrome</strong> – Patients with pyomyositis of the extremities may develop compartment syndrome, a surgical emergency [<a href="#rid2">2,7,17,81,98-100</a>]. This condition should be suspected in patients whose pain suddenly worsens or extends circumferentially. Compartment syndrome is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Septic pulmonary emboli</strong> – Several reports of septic pulmonary emboli suggest that primary pyomyositis due to <em>S. aureus</em> may cause embolic events even in the absence of infective endocarditis or appreciable venous thrombosis on imaging [<a href="#rid101">101-107</a>]. Most reports describe the presence of concomitant staphylococcal bacteremia. Symptoms of septic pulmonary emboli include cough, shortness of breath, and pleuritic chest pain. Further discussion of septic pulmonary emboli is found elsewhere. (See  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H2165887389"><span class="h2">When to suspect pyomyositis</span><span class="headingEndMark"> — </span>The diagnosis of primary pyomyositis should be suspected in adults and children with pain that localizes to a specific muscle, most often in an extremity. It should also be considered in patients with hip or low back pain that steadily worsens over several days, especially if they are a child or are pregnant or have a fever or leukocytosis.</p><p>Diagnosis of primary pyomyositis is often delayed due to the nonspecific nature of muscle pain, especially in children. A careful physical examination, frequent follow-up, and a low threshold for further workup may help to prevent delays in therapy and consequent complications.</p><p class="headingAnchor" id="H3841560882"><span class="h2">Diagnostic evaluation</span><span class="headingEndMark"> — </span>The diagnosis of pyomyositis is confirmed by aspiration of pus or identification of an organism from specimens collected from the involved muscle. A presumptive diagnosis is based on specific radiographic and physical exam findings, especially when blood cultures are positive.</p><p>When pyomyositis is suspected, we perform the following tests:</p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination to localize the site of disease. (See <a class="local">'Anatomic sites of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blood tests for complete blood count with differential, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and procalcitonin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two sets of blood cultures drawn from separate peripheral venous sites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Magnetic resonance imaging (MRI) with gadolinium (preferred). If MRI is not an option, ultrasound or computed tomography (CT) with intravenous contrast of the involved area can be helpful. (See <a class="local">'Radiographic imaging'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gram stain and culture of fluid or tissue from the involved muscle.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional testing if complications are suspected, as described elsewhere. (See <a class="local">'Additional tests'</a> below.)</p><p></p><p class="headingAnchor" id="H99610848"><span class="h3">Radiographic imaging</span><span class="headingEndMark"> — </span>Radiographic imaging is the most useful tool for defining the site(s) and extent of infection and for ruling out other conditions.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Magnetic resonance imaging</strong> – MRI with gadolinium is the preferred imaging technique [<a href="#rid1">1,17,30,41,87,92,108-111</a>]. It is highly sensitive for abscess, muscle inflammation, and infection of adjacent structures  (<a class="graphic graphic_diagnosticimage graphicRef140858" href="/d/graphic/140858.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef140859" href="/d/graphic/140859.html" rel="external">image 2</a> and <a class="graphic graphic_diagnosticimage graphicRef140860" href="/d/graphic/140860.html" rel="external">image 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrasound</strong> – Ultrasonography is less sensitive than MRI, especially for muscle inflammation in the absence of an abscess or for pelvic abscesses. It can be helpful for ultrasonographic-guided sampling and drainage of purulent material  (<a class="graphic graphic_diagnosticimage graphicRef93854" href="/d/graphic/93854.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef140860" href="/d/graphic/140860.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef140861" href="/d/graphic/140861.html" rel="external">image 5</a>) [<a href="#rid2">2,15,17,92,112-115</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Computed tomography</strong> – CT with intravenous contrast can detect muscle swelling and abscess but it is often unable to define the full extent of muscle involvement and is sometimes unable to distinguish abscess from hematoma  (<a class="graphic graphic_diagnosticimage graphicRef90457" href="/d/graphic/90457.html" rel="external">image 6</a>) [<a href="#rid17">17,92,114,116</a>]. Like ultrasound, it is helpful for guided drainage of purulent material  (<a class="graphic graphic_diagnosticimage graphicRef140862" href="/d/graphic/140862.html" rel="external">image 7</a> and <a class="graphic graphic_diagnosticimage graphicRef140863" href="/d/graphic/140863.html" rel="external">image 8</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other imaging tests</strong> – Nuclear medicine scans, such as gallium or positron-emission tomography (PET/CT) scans, are generally unnecessary but can demonstrate locations of multifocal pyomyositis [<a href="#rid15">15,17,21</a>]. Plain radiographs (x-rays) and bone scans are not helpful. (See  <a class="medical medical_review" href="/d/html/6921.html" rel="external">"Imaging techniques for evaluation of the painful joint", section on 'Nuclear medicine'</a> and  <a class="medical medical_review" href="/d/html/2736.html" rel="external">"Fever of unknown origin in adults: Evaluation and management", section on 'Whole-body imaging'</a>.)</p><p></p><p class="headingAnchor" id="H13"><span class="h3">Microbiologic tests</span><span class="headingEndMark"> — </span>Microbiologic findings are necessary to confirm the diagnosis of pyomyositis. In clinically stable patients, we obtain samples prior to administration of antibiotics to optimize yield from culture.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abscess or muscle specimens</strong> – Samples should be obtained via ultrasound-guided abscess aspiration, muscle biopsy, or a surgical procedure and should be sent for Gram stain and culture (aerobic and anaerobic). A positive Gram stain or culture from the involved muscle confirms the diagnosis [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood cultures</strong> – Positive blood cultures are highly suggestive of the diagnosis in patients with consistent clinical and imaging findings. Based on available data, blood cultures are positive in 10 to 53 percent of cases [<a href="#rid1">1-3,5,7,10,21,32</a>].</p><p></p><p class="headingAnchor" id="H3667642676"><span class="h3">Additional tests</span><span class="headingEndMark"> — </span>In certain situations, additional testing may be indicated to evaluate for complications or concomitant conditions.</p><p>We perform the following tests, based on the clinical scenario:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Echocardiography in patients with </strong><strong><em>S. aureus </em></strong><strong>bacteremia</strong> – All patients with confirmed <em>S. aureus </em>bacteremia should undergo evaluation for endocarditis, including echocardiogram, as described elsewhere [<a href="#rid47">47</a>]. In patients with <em>S. aureus </em>pyomyositis whose blood cultures are negative but were drawn after administration of antibiotics, we also obtain echocardiography. (See  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults", section on 'Clinical approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arthrocentesis or bone biopsy</strong> – For patients with clinical findings or radiographic imaging consistent with concomitant septic arthritis or osteomyelitis, arthrocentesis or bone biopsy can confirm the diagnosis. To avoid contamination of the sample, joint, or bone, we utilize ultrasound to avoid passing the needle though the infected muscle. For patients undergoing surgical drainage for pyomyositis, sampling and pre-emptive joint or bone debridement can be performed during surgery.</p><p></p><p class="bulletIndent1">In some situations (eg, suspected infection of pelvic joints or bones), bone or joint fluid sampling may be deferred due to anatomic risks associated with obtaining the sample. In this situation, empiric treatment for septic arthritis or osteomyelitis may be warranted based on imaging. Further discussion of septic arthritis and osteomyelitis are found elsewhere. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a> and  <a class="medical medical_review" href="/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Measurement of compartment pressures</strong> – When compartment syndrome is suspected, measurement of compartment pressures can be confirmatory. Further information regarding compartment syndrome is found elsewhere. (See  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Measurement of compartment pressures'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest imaging</strong> – Patients with symptoms of pulmonary infection (eg, cough, shortness of breath, chest pain) should undergo chest imaging (eg, CT scan without contrast) to rule out septic pulmonary emboli.</p><p></p><p class="headingAnchor" id="H1176386729"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for primary pyomyositis is broad and primarily involves conditions that cause focal muscle pain.</p><p>In children who present with a limp and are unable to verbalize pain, the differential is even broader and is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/6460.html" rel="external">"Overview of the causes of limp in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with focal muscle pain and no signs of infection (eg, no fever, leukocytosis)</strong> – Because the early stage of primary pyomyositis often has no associated signs of infection, misdiagnosis as a noninfectious syndrome is common.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Muscle strain, tear, contusion, or hematoma</strong> – Patients with these conditions usually report sudden motion just prior to onset of symptoms. These conditions steadily improve without antibiotics, whereas pyomyositis worsens without antibiotics. (See  <a class="medical medical_review" href="/d/html/13812.html" rel="external">"Quadriceps muscle and tendon injuries", section on 'Quadriceps strain'</a> and  <a class="medical medical_review" href="/d/html/13812.html" rel="external">"Quadriceps muscle and tendon injuries", section on 'Quadriceps and patellar tendon tears'</a> and  <a class="medical medical_review" href="/d/html/13810.html" rel="external">"Hamstring muscle and tendon injuries", section on 'Clinical presentation and examination'</a> and  <a class="medical medical_review" href="/d/html/90232.html" rel="external">"Calf injuries not involving the Achilles tendon", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents", section on 'Muscle strain or tear'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diabetic muscle infarction (ie, spontaneous diabetic myonecrosis)</strong> – This syndrome presents with pain, swelling, and tenderness in a thigh or calf that can be acute or evolve over days or weeks without a history of preceding trauma. Imaging usually shows edema and muscle destruction without abscess, which can be difficult to distinguish from the early stages of pyomyositis. Unlike pyomyositis, diabetic muscle infarction gradually improves without antibiotic therapy. (See  <a class="medical medical_review" href="/d/html/5135.html" rel="external">"Diabetic muscle infarction"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Deep vein thrombosis (DVT)</strong> – Calf pain, tenderness, and erythema is frequently due to DVT and can be easily diagnosed by ultrasound confirming the presence of venous clot. (See  <a class="medical medical_review" href="/d/html/1351.html" rel="external">"Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Compartment syndrome</strong> – Compartment syndrome presents with deep diffuse severe pain and tenseness in the entire muscle compartment of an extremity. The rapidity and severity of progression help to differentiate it from early pyomyositis. Neurologic and vascular symptoms (eg, paresthesias, pallor) indicate advanced disease. (See  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sarcoma</strong> – Soft tissue sarcomas present as slow-growing painless muscle masses, features which help to differentiate them from pyomyositis. (See  <a class="medical medical_review" href="/d/html/14259.html" rel="external">"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with signs of infection</strong> – The presence of focal muscle pain with fever, leukocytosis, or systemic toxicity (hypotension, tachycardia) may suggest any of the following etiologies:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Septic arthritis</strong> – In the extremities, differentiating joint infection from pyomyositis is straightforward because pain, tenderness, and edema localize to the site of infection. When infection involves the hip, pelvis, or shoulder, the correct diagnosis requires careful musculoskeletal exam; any movement of the joint elicits pain in septic arthritis, whereas pyomyositis may only elicit pain when the direction of movement affects the involved muscle. Imaging and arthrocentesis are often necessary to differentiate these conditions [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Osteomyelitis</strong> – Osteomyelitis typically has deeper and less severe tenderness than pyomyositis. However, psoas abscess can be challenging to differentiate from vertebral osteomyelitis based on exam alone, and MRI is often necessary. (See  <a class="medical medical_review" href="/d/html/7652.html" rel="external">"Psoas abscess"</a> and  <a class="medical medical_review" href="/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults", section on 'Suggested clinical approach'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clostridial myonecrosis (gas gangrene)</strong> – This condition is usually caused by direct penetrating trauma. The overlying skin is discolored, tense, and exquisitely tender, and patients have systemic toxicity, crepitus on exam, and gas in the soft tissue on imaging  (<a class="graphic graphic_table graphicRef68260" href="/d/graphic/68260.html" rel="external">table 1</a>) (See  <a class="medical medical_review" href="/d/html/7672.html" rel="external">"Clostridial myonecrosis", section on 'Clostridial myonecrosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Necrotizing myositis due to beta-hemolytic </strong><strong><em>Streptococcus</em></strong><strong> (eg, group A </strong><strong><em>Streptococcus</em></strong> <strong>[GAS])</strong> – Fulminant gangrenous muscle destruction with systemic toxicity characterize this rare condition which may or may not have overlying skin changes. (See  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections", section on 'Necrotizing myositis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cellulitis and necrotizing fasciitis</strong> – Both of these conditions involve erythema and other skin changes (eg, bullae, ecchymosis) that are not seen in pyomyositis. Compared with pyomyositis, necrotizing fasciitis progresses more rapidly and has firm and indurated skin that often disallows delineation of the underlying muscle on exam  (<a class="graphic graphic_table graphicRef68260" href="/d/graphic/68260.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/110529.html" rel="external">"Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Appendicitis</strong> – Pyomyositis of the right hip and pelvis muscles has been confused with appendicitis, especially in children. In some cases, patients have undergone unnecessary surgery for appendectomy due to nonspecific findings on CT scan [<a href="#rid2">2,17,21</a>]. Signs that may help to differentiate appendicitis include antecedent periumbilical pain, anorexia, vomiting, pain in the right lower quadrant with palpation on the left side (ie, Rovsing sign), and rebound tenderness. (See  <a class="medical medical_review" href="/d/html/6479.html" rel="external">"Acute appendicitis in children: Clinical manifestations and diagnosis", section on 'Common signs and symptoms'</a> and  <a class="medical medical_review" href="/d/html/1386.html" rel="external">"Acute appendicitis in adults: Clinical manifestations and differential diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The cornerstones of treatment of pyomyositis are abscess drainage and antibiotic therapy.</p><p class="headingAnchor" id="H3518868908"><span class="h2">Drainage</span><span class="headingEndMark"> — </span>Surgical or image-guided percutaneous drainage is indicated for patients who have an abscess [<a href="#rid1">1,111</a>].</p><p>Often, image-guided percutaneous drainage is performed at the time of diagnostic sampling of the abscess. If percutaneous drainage does not completely empty the abscess, surgical debridement is indicated. Other indications for immediate surgical drainage include extensive muscle involvement, complex loculated abscesses, toxic shock syndrome (TSS), and suspected compartment syndrome.</p><p>There are no data comparing percutaneous drainage to surgical drainage for pyomyositis. For psoas abscess, drainage procedures are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/7652.html" rel="external">"Psoas abscess", section on 'Drainage'</a>.)</p><p class="headingAnchor" id="H3642910102"><span class="h2">Antibiotic therapy</span></p><p class="headingAnchor" id="H3018800199"><span class="h3">Initial antibiotic selection</span><span class="headingEndMark"> — </span>Initial selection of antibiotics is based on the suspected bacterial etiology as well as the patient's severity of illness and underlying medical conditions. Prior to selecting empiric antibiotics, any prior culture results from recent infections should be reviewed to help guide therapy.</p><p>We administer intravenous antibiotic formulations as initial therapy, in accordance with expert guidelines  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>) [<a href="#rid1">1,111</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunocompetent patients without sepsis</strong> – These patients, especially those who are young and healthy, can be treated with monotherapy with an agent that covers <em>S. aureus </em>(including methicillin-resistant <em>S. aureus </em>[MRSA]) and group A <em>Streptococcus</em> (GAS)<em> </em>[<a href="#rid1">1</a>]<em>.</em></p><p></p><p class="bulletIndent1">We suggest one of the following regimens (dosages are listed in the algorithm  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>)):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intravenous <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> (preferred). Dosages for adults and children are found in the tables  (<a class="graphic graphic_table graphicRef128911" href="/d/graphic/128911.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef129344" href="/d/graphic/129344.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9304" href="/d/drug information/9304.html" rel="external">Daptomycin</a> (alternative).</p><p></p><p class="bulletIndent1">Alternative agents that should be restricted and only used when <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> and <a class="drug drug_general" data-topicid="9304" href="/d/drug information/9304.html" rel="external">daptomycin</a> are not options are listed in the table (only adult dosing is listed  (<a class="graphic graphic_table graphicRef110072" href="/d/graphic/110072.html" rel="external">table 4</a>)).</p><p></p><p class="bulletIndent1">Once a pathogen is identified, therapy should be tailored to target the organism, as described elsewhere. (See <a class="local">'Directed therapy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with sepsis or an immunocompromising condition</strong> – For these patients, we administer broad-spectrum antibiotics that cover <em>S. aureus </em>(including MRSA), GAS, gram-negative bacilli, and anaerobes [<a href="#rid1">1,111</a>].</p><p></p><p class="bulletIndent1">We suggest one of the following regimens (dosages are listed in the algorithm  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>)):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intravenous <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> (dosages for adults and children are found in the tables and algorithm  (<a class="graphic graphic_table graphicRef128911" href="/d/graphic/128911.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef129344" href="/d/graphic/129344.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>))</p><p></p><p class="bulletIndent2"><strong>PLUS</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9777" href="/d/drug information/9777.html" rel="external">Piperacillin-tazobactam</a>, <strong>or </strong><a class="drug drug_general" data-topicid="9613" href="/d/drug information/9613.html" rel="external">meropenem</a>, <strong>or </strong>combination therapy with <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a> and intravenous <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>.</p><p></p><p class="bulletIndent1">If septic shock is present, we add intravenous <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> to the above regimen until streptococcal TSS is ruled out  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>). Diagnosis and treatment of streptococcal TSS are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/3162.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis", section on 'Toxic shock syndrome'</a> and  <a class="medical medical_review" href="/d/html/3169.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Treatment and prevention", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent1">For patients who have an immediate immunoglobulin (Ig)E-mediated beta-lactam allergy, we suggest a regimen of <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> plus intravenous <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> plus intravenous <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>). Although many patients have reported beta-lactam allergies, most do not have allergies that would prohibit the use of beta-lactams. In particular, many with penicillin allergies can still take a cephalosporin or carbapenem. Evaluation and management of reported penicillin allergies are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/111361.html" rel="external">"Choice of antibiotics in penicillin-allergic hospitalized patients"</a> and  <a class="medical medical_review" href="/d/html/2087.html" rel="external">"Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics"</a>.)</p><p></p><p class="bulletIndent1">There is spectrum of immunocompromising conditions that predispose to atypical pathogens in patients with pyomyositis (see <a class="local">'Immunocompromising condition'</a> above). Ultimately, the decision to use a broader spectrum regimen requires clinical judgement.</p><p></p><p class="headingAnchor" id="H55210399"><span class="h3">Directed therapy</span><span class="headingEndMark"> — </span>Once an organism is identified, the antibiotic regimen should be narrowed to target the causative organism.</p><p>A transition to oral therapy can occur after the patient has clinically improved, bloodstream infection has cleared (if initially detected), and there is no residual abscess or evidence of endocarditis; we generally continue intravenous therapy for at least 48 hours [<a href="#rid1">1,111</a>]. Of note, patients who have certain complications, such as <em>S. aureus </em>bacteremia, are managed with prolonged antibiotics [<a href="#rid1">1,111</a>]. (See <a class="local">'Duration of therapy'</a> below and  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults"</a> and  <a class="medical medical_review" href="/d/html/5967.html" rel="external">"Staphylococcus aureus bacteremia in children: Management and outcome", section on 'Management'</a>.)</p><p>Example regimens for the three most common pathogens include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Methicillin-sensitive </strong><strong><em>S. aureus </em></strong><strong>(MSSA)</strong> – For MSSA infections, we treat with <a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a>, <a class="drug drug_general" data-topicid="9674" href="/d/drug information/9674.html" rel="external">nafcillin</a>, <a class="drug drug_general" data-topicid="9724" href="/d/drug information/9724.html" rel="external">oxacillin</a>, or intravenous flucloxacillin. For oral therapy, we switch to <a class="drug drug_general" data-topicid="9349" href="/d/drug information/9349.html" rel="external">dicloxacillin</a>, flucloxacillin, <a class="drug drug_general" data-topicid="9231" href="/d/drug information/9231.html" rel="external">cephalexin</a>, or <a class="drug drug_general" data-topicid="9212" href="/d/drug information/9212.html" rel="external">cefadroxil</a>. Oral options for patients with serious beta-lactam allergy include <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a>, <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, and <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a>. We generally avoid <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> due to its risk for causing <em>Clostridium difficile </em>infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Methicillin-resistant </strong><strong><em>S. aureus </em></strong><strong>(MRSA)</strong> – For MRSA infections, we continue treatment with parenteral <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> or <a class="drug drug_general" data-topicid="9304" href="/d/drug information/9304.html" rel="external">daptomycin</a>. For oral therapy, options include <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a>, and <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a>. We generally avoid <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> due to its risk for causing <em>C. difficile </em>infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Group A </strong><strong><em>Streptococcus </em></strong><strong>(GAS)</strong> – For infections due to GAS (ie, <em>Streptococcus pyogenes)</em>, we change to parenteral <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a>, <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a>, or <a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a>. If TSS is present, we add or continue parenteral <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> and consider administration of intervenous <a class="drug drug_general" data-topicid="16471" href="/d/drug information/16471.html" rel="external">immune globulin</a>. Treatment of streptococcal TSS is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/3169.html" rel="external">"Invasive group A streptococcal infection and toxic shock syndrome: Treatment and prevention", section on 'Treatment'</a>.)</p><p></p><p>For patients infected with other pathogens, antibiotic selection should be based on the organism's susceptibility profile and patient tolerance.</p><p class="headingAnchor" id="H1773285772"><span class="h3">Duration of therapy</span><span class="headingEndMark"> — </span>Duration of therapy should be individualized based on clinical response. Most patients require a total of two to four weeks of antibiotic therapy, although patients with extensive, multifocal, or poorly drained infection may warrant longer courses [<a href="#rid1">1,111</a>].</p><p>Patients who have complications, such as <em>S. aureus </em>bacteremia, septic arthritis, or osteomyelitis, generally require prolonged courses of intravenous antibiotics, as described elsewhere. (See  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults"</a> and  <a class="medical medical_review" href="/d/html/5967.html" rel="external">"Staphylococcus aureus bacteremia in children: Management and outcome", section on 'Management'</a> and  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults", section on 'Antibiotic therapy'</a> and  <a class="medical medical_review" href="/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment", section on 'Antibiotic therapy'</a>.)</p><p class="headingAnchor" id="H1629821939"><span class="h1">MONITORING RESPONSE TO THERAPY</span><span class="headingEndMark"> — </span>Patients should be closely monitored during therapy to ensure steady improvement of symptoms, exam findings, and lab tests (eg, white blood cell, C-reactive protein [CRP]). Follow-up imaging is typically unnecessary in patients who respond well to therapy.</p><p class="headingAnchor" id="H1940481551"><span class="h1">REFRACTORY OR RECURRENT INFECTION</span><span class="headingEndMark"> — </span>Failure to respond after drainage and 24 to 48 hours of appropriate antibiotic therapy should prompt further assessment. A common reason for failure is inadequate drainage of an initial abscess or development of a new abscess; available data suggest that 10 to 25 percent of infected individuals require multiple drainage procedures [<a href="#rid7">7,117</a>]. Radiographic imaging can help to detect residual abscess.</p><p>In refractory cases, complications such as compartment syndrome or septic arthritis should also be considered. Additionally, culture results and antibiotic dosing should be reviewed; broadening the antibiotic regimen may be appropriate in culture-negative cases. In these cases, molecular techniques may be needed to define a pathogen. (See <a class="local">'Complications'</a> above.)</p><p>Recurrences after complete resolution of infection are rare [<a href="#rid3">3,17</a>].</p><p class="headingAnchor" id="H576798350"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>The overall mortality from primary pyomyositis is undefined; in case studies and systematic reviews, mortality has ranged from zero to 10 percent [<a href="#rid3">3,7,32,39,118</a>].</p><p>Long-term sequelae appear to be uncommon, although residual weakness and disfigurement at the site of infection have been reported [<a href="#rid7">7,15,119</a>].</p><p class="headingAnchor" id="H3119550134"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110086.html" rel="external">"Society guideline links: Skin and soft tissue infections"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geographic prevalence</strong> – Primary pyomyositis is a purulent infection of skeletal muscle that arises from hematogenous spread, often with abscess formation. It is classically an infection of the tropics, although it has been recognized in temperate climates with increasing frequency. (See <a class="local">'Geographic prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors associated with pyomyositis include young age, prior vigorous exercise or nonpenetrating muscle trauma, immunocompromising conditions (particularly HIV infection), pregnancy, and injection drug use disorders. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>Staphylococcus aureus</em> (including methicillin-resistant strains) is the most common cause of pyomyositis; it causes up to 90 percent of tropical cases and up to 75 percent of temperate cases. Group A <em>Streptococcus </em>(GAS)<em> </em>is also a common cause, especially in children. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Pyomyositis presents with fever and pain localized to a single muscle group. It develops most often in the lower extremity, but any muscle group can be involved, including the iliopsoas and muscles of the hip and pelvis. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Aspiration of pus or detection of an organism from specimens of involved muscle confirms the diagnosis. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Radiographic imaging</strong> – MRI is the most useful radiographic tool to diagnosis pyomyositis, define the extent of infection, and rule out other entities. (See <a class="local">'Radiographic imaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Microbiologic tests</strong> – Bacteriologic diagnosis is secured by Gram stain and culture of drainage specimens and/or blood cultures. (See <a class="local">'Microbiologic tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis is broad and includes noninfectious and infectious conditions. In the early stages of illness, it is commonly misdiagnosed as muscle strain, especially if fever is absent. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – In the absence of an abscess, pyomyositis can be treated with antibiotics alone. Abscesses require drainage and antibiotic therapy. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">For initial therapy for immunocompetent individuals without sepsis, we suggest an intravenous antibiotic directed against staphylococci and beta-hemolytic streptococci (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). For patients with sepsis or an immunocompromising condition, we suggest broadened antibiotic coverage that covers gram-positive, gram-negative, and anaerobic organisms (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Antibiotic regimens are outlined in the algorithm  (<a class="graphic graphic_algorithm graphicRef140807" href="/d/graphic/140807.html" rel="external">algorithm 1</a>).</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59:147.</a></li><li><a class="nounderline abstract_t">Taksande A, Vilhekar K, Gupta S. Primary pyomyositis in a child. Int J Infect Dis 2009; 13:e149.</a></li><li><a class="nounderline abstract_t">Crum NF. Bacterial pyomyositis in the United States. Am J Med 2004; 117:420.</a></li><li><a class="nounderline abstract_t">Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg Am 2002; 84-A:2277.</a></li><li><a class="nounderline abstract_t">Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans): current perspective. Postgrad Med J 2004; 80:267.</a></li><li><a class="nounderline abstract_t">Horn CV, Master S. Pyomyositis tropicans in Uganda. East Afr Med J 1968; 45:463.</a></li><li><a class="nounderline abstract_t">Moriarty P, Leung C, Walsh M, Nourse C. Increasing pyomyositis presentations among children in Queensland, Australia. Pediatr Infect Dis J 2015; 34:1.</a></li><li><a class="nounderline abstract_t">Maravelas R, Melgar TA, Vos D, et al. Pyomyositis in the United States 2002-2014. J Infect 2020; 80:497.</a></li><li><a class="nounderline abstract_t">Comegna L, Guidone PI, Prezioso G, et al. Pyomyositis is not only a tropical pathology: a case series. J Med Case Rep 2016; 10:372.</a></li><li><a class="nounderline abstract_t">Evans JA, Ewald MB. Pyomyositis: a fatal case in a healthy teenager. Pediatr Emerg Care 2005; 21:375.</a></li><li><a class="nounderline abstract_t">Elzohairy MM. Primary pyomyositis in children. Orthop Traumatol Surg Res 2018; 104:397.</a></li><li><a class="nounderline abstract_t">Levin MJ, Gardner P, Waldvogel FA. “Tropical” pyomyositis. An unusual infection due to staphylococcus aureus. N Engl J Med 1971; 284:196.</a></li><li><a class="nounderline abstract_t">Verma S. Pyomyositis in Children. Curr Infect Dis Rep 2016; 18:12.</a></li><li><a class="nounderline abstract_t">Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis 1992; 15:668.</a></li><li><a class="nounderline abstract_t">Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J 2000; 19:1009.</a></li><li><a class="nounderline abstract_t">Unnikrishnan PN, Perry DC, George H, et al. Tropical primary pyomyositis in children of the UK: an emerging medical challenge. Int Orthop 2010; 34:109.</a></li><li><a class="nounderline abstract_t">Abbati G, Abu Rumeileh S, Perrone A, et al. Pelvic Pyomyositis in Childhood: Clinical and Radiological Findings in a Tertiary Pediatric Center. Children (Basel) 2022; 9.</a></li><li><a class="nounderline abstract_t">Kiran M, Mohamed S, Newton A, et al. Pelvic pyomyositis in children: changing trends in occurrence and management. Int Orthop 2018; 42:1143.</a></li><li><a class="nounderline abstract_t">Verma S, Singhi SC, Marwaha RK, et al. Tropical pyomyositis in children: 10 years experience of a tertiary care hospital in northern India. J Trop Pediatr 2013; 59:243.</a></li><li><a class="nounderline abstract_t">Kerrigan KR, Nelson SJ. Tropical pyomyositis in eastern Ecuador. Trans R Soc Trop Med Hyg 1992; 86:90.</a></li><li><a class="nounderline abstract_t">Spiegel DA, Meyer JS, Dormans JP, et al. Pyomyositis in children and adolescents: report of 12 cases and review of the literature. J Pediatr Orthop 1999; 19:143.</a></li><li><a class="nounderline abstract_t">Widrow CA, Kellie SM, Saltzman BR, Mathur-Wagh U. Pyomyositis in patients with the human immunodeficiency virus: an unusual form of disseminated bacterial infection. Am J Med 1991; 91:129.</a></li><li><a class="nounderline abstract_t">Burkhart BG, Hamson KR. Pyomyositis in a 69-year-old tennis player. Am J Orthop (Belle Mead NJ) 2003; 32:562.</a></li><li><a class="nounderline abstract_t">Chusid MJ, Hill WC, Bevan JA, Sty JR. Proteus pyomyositis of the piriformis muscle in a swimmer. Clin Infect Dis 1998; 26:194.</a></li><li><a class="nounderline abstract_t">Jayoussi R, Bialik V, Eyal A, et al. Pyomyositis caused by vigorous exercise in a boy. Acta Paediatr 1995; 84:226.</a></li><li><a class="nounderline abstract_t">King RJ, Laugharne D, Kerslake RW, Holdsworth BJ. Primary obturator pyomyositis: a diagnostic challenge. J Bone Joint Surg Br 2003; 85:895.</a></li><li><a class="nounderline abstract_t">Koutures CG, Savoia M, Pedowitz RA. Staphylococcus aureus thigh pyomyositis in a collegiate swimmer. Clin J Sport Med 2000; 10:297.</a></li><li><a class="nounderline abstract_t">Meehan J, Grose C, Soper RT, Kimura K. Pyomyositis in an adolescent female athlete. J Pediatr Surg 1995; 30:127.</a></li><li><a class="nounderline abstract_t">Viani RM, Bromberg K, Bradley JS. Obturator internus muscle abscess in children: report of seven cases and review. Clin Infect Dis 1999; 28:117.</a></li><li><a class="nounderline abstract_t">Karmazyn B, Kleiman MB, Buckwalter K, et al. Acute pyomyositis of the pelvis: the spectrum of clinical presentations and MR findings. Pediatr Radiol 2006; 36:338.</a></li><li><a class="nounderline abstract_t">Amoozgar B, Kaushal V, Garsondiya B. Primary Pyomyositis: Contact Sports as the Rare Risk Factors. Case Rep Infect Dis 2019; 2019:5739714.</a></li><li class="breakAll">Stevens D, Bryant A. Group A streptococcal and staphylococcal infections. In: Tropical infections diseases: Principles, pathogens, and practice, 3, Guerrant R, Walker D, Weller P (Eds), Elsevier Saunders, Edinburgh 2011. p.209.</li><li><a class="nounderline abstract_t">Rodgers WB, Yodlowski ML, Mintzer CM. Pyomyositis in patients who have the human immunodeficiency virus. Case report and review of the literature. J Bone Joint Surg Am 1993; 75:588.</a></li><li><a class="nounderline abstract_t">Ansalonl L, Acaye GL, Re MC. High HIV seroprevalence among patients with pyomyositis in northern Uganda. Trop Med Int Health 1996; 1:210.</a></li><li><a class="nounderline abstract_t">Blumberg HM, Stephens DS. Pyomyositis and human immunodeficiency virus infection. South Med J 1990; 83:1092.</a></li><li><a class="nounderline abstract_t">Jellis JE. Viral infections: musculoskeletal infection in the human immunodeficiency virus (HIV) infected patient. Baillieres Clin Rheumatol 1995; 9:121.</a></li><li><a class="nounderline abstract_t">Holbrook KA, Klein RS, Hartel D, et al. Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:301.</a></li><li><a class="nounderline abstract_t">Miller M, Cespedes C, Vavagiakis P, et al. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22:463.</a></li><li><a class="nounderline abstract_t">Ngor C, Hall L, Dean JA, Gilks CF. Factors associated with pyomyositis: A systematic review and meta-analysis. Trop Med Int Health 2021; 26:1210.</a></li><li><a class="nounderline abstract_t">Coombs S, Bui A, Mirzan HS, et al. Pyomyositis presenting as myonecrosis secondary to methicillin-resistant Staphylococcus aureus bacteremia in chronic lymphocytic leukemia. Proc (Bayl Univ Med Cent) 2022; 35:665.</a></li><li><a class="nounderline abstract_t">Small LN, Ross JJ. Tropical and temperate pyomyositis. Infect Dis Clin North Am 2005; 19:981.</a></li><li><a class="nounderline abstract_t">Schwartzman WA, Lambertus MW, Kennedy CA, Goetz MB. Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus. Am J Med 1991; 90:595.</a></li><li><a class="nounderline abstract_t">Gomez-Reino JJ, Aznar JJ, Pablos JL, et al. Nontropical pyomyositis in adults. Semin Arthritis Rheum 1994; 23:396.</a></li><li><a class="nounderline abstract_t">Belsky DS, Teates CD, Hartman ML. Case report: diabetes mellitus as a predisposing factor in the development of pyomyositis. Am J Med Sci 1994; 308:251.</a></li><li><a class="nounderline abstract_t">Hsueh PR, Hsiue TR, Hsieh WC. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis 1996; 22:858.</a></li><li><a class="nounderline abstract_t">Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am 2002; 16:697.</a></li><li><a class="nounderline abstract_t">Lo TS, Mooers MG, Wright LJ. Pyomyositis complicating acute bacterial endocarditis in an intravenous drug user. N Engl J Med 2000; 342:1614.</a></li><li><a class="nounderline abstract_t">Crossley M. Temperate pyomyositis in an injecting drug misuser. A difficult diagnosis in a difficult patient. Emerg Med J 2003; 20:299.</a></li><li><a class="nounderline abstract_t">Rayes AA, Nobre V, Teixeira DM, et al. Tropical pyomyositis and human toxocariasis: a clinical and experimental study. Am J Med 2000; 109:422.</a></li><li><a class="nounderline abstract_t">Hossain A, Reis ED, Soundararajan K, et al. Nontropical pyomyositis: analysis of eight patients in an urban center. Am Surg 2000; 66:1064.</a></li><li><a class="nounderline abstract_t">Montazeri N, Athale UH, Fulford M, Tarnopolsky MA. Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia: Case Report and Review of the Literature. J Pediatr Hematol Oncol 2015; 37:223.</a></li><li><a class="nounderline abstract_t">Fukushima T, Iwao H, Nakazima A, et al. MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy. Anticancer Res 2009; 29:3361.</a></li><li><a class="nounderline abstract_t">Singh P, Chan W, Blomfield P, McIntosh R. Pyomyositis after chemotherapy for endometrial cancer. Int J Gynecol Cancer 2010; 20:1256.</a></li><li><a class="nounderline abstract_t">Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Pyomyositis associated with hematological malignancy: case report and review of the literature. Int J Infect Dis 2008; 12:120.</a></li><li><a class="nounderline abstract_t">Kompa KG, Trottier CA, Hyman CL, Kohli R. Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease. Open Forum Infect Dis 2022; 9:ofac385.</a></li><li><a class="nounderline abstract_t">Kalra S, Damle NA, Gupta SD, et al. Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on 18F-FDG PET-CT. Indian J Nucl Med 2022; 37:192.</a></li><li><a class="nounderline abstract_t">Migliarino V, Naviglio S, Barbi E, Rabusin M. Pseudomonas aeruginosa Pyomyositis in a Child With Acute Lymphoblastic Leukemia: A Case Report and Review of Literature. J Pediatr Hematol Oncol 2021; 43:e795.</a></li><li><a class="nounderline abstract_t">Yang HW, Wu UI, Hsieh JH, Tai HC. How long should we treat Candida albicans pyomyositis? Insight from a cured case. J Microbiol Immunol Infect 2020; 53:665.</a></li><li><a class="nounderline abstract_t">Xipell M, Ventura-Aguiar P, Revuelta I, et al. Pyomyositis in a Patient with IgA Nephropathy and Kidney Transplant. Case Rep Transplant 2019; 2019:7305683.</a></li><li><a class="nounderline abstract_t">Wig S, McCabe PS, Swamy S, et al. Pyomyositis: an unusual cause of hip pain in a patient on certolizumab pegol and leflunomide. Rheumatology (Oxford) 2018; 57:1685.</a></li><li><a class="nounderline abstract_t">Chen YH, Lu CC, Chen HC. Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus. J Rheumatol 2018; 45:286.</a></li><li><a class="nounderline abstract_t">Minami K, Kenzaka T, Kumabe A, Matsumura M. Thigh pyomyositis caused by group A streptococcus in an immunocompetent adult without any cause. BMC Res Notes 2017; 10:33.</a></li><li><a class="nounderline abstract_t">Vigil KJ, Johnson JR, Johnston BD, et al. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010; 50:374.</a></li><li><a class="nounderline abstract_t">Colmegna I, Justiniano M, Espinoza LR, Gimenez CR. Piriformis pyomyositis with sciatica: an unrecognized complication of "unsafe" abortions. J Clin Rheumatol 2007; 13:87.</a></li><li><a class="nounderline abstract_t">Kennedy B, Botros K, Rashid H, Bermingham J. Unprovoked piriformis myositis presenting in a pregnant patient. BMJ Case Rep 2022; 15.</a></li><li><a class="nounderline abstract_t">Kinahan AM, Douglas MJ. Piriformis pyomyositis mimicking epidural abscess in a parturient. Can J Anaesth 1995; 42:240.</a></li><li><a class="nounderline abstract_t">Wong CH, Choi SH, Wong KY. Piriformis pyomyositis: a report of three cases. J Orthop Surg (Hong Kong) 2008; 16:389.</a></li><li><a class="nounderline abstract_t">Wong LF, Mullers S, McGuinness E, et al. Piriformis pyomyositis, an unusual presentation of leg pain post partum--case report and review of literature. J Matern Fetal Neonatal Med 2012; 25:1505.</a></li><li><a class="nounderline abstract_t">Siddiq MAB, Rasker JJ. Piriformis pyomyositis, a cause of piriformis syndrome-a systematic search and review. Clin Rheumatol 2019; 38:1811.</a></li><li><a class="nounderline abstract_t">Chiedozi LC. Pyomyositis. Review of 205 cases in 112 patients. Am J Surg 1979; 137:255.</a></li><li><a class="nounderline abstract_t">Martínez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701.</a></li><li><a class="nounderline abstract_t">Ruiz ME, Yohannes S, Wladyka CG. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2005; 352:1488.</a></li><li><a class="nounderline abstract_t">Zalavras CG, Rigopoulos N, Poultsides L, Patzakis MJ. Increased oxacillin resistance in thigh pyomyositis in diabetic patients. Clin Orthop Relat Res 2008; 466:1405.</a></li><li><a class="nounderline abstract_t">Fowler A, Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. J Med Microbiol 2006; 55:123.</a></li><li><a class="nounderline abstract_t">Wang TK, Wong SS, Woo PC. Two cases of pyomyositis caused by Klebsiella pneumoniae and review of the literature. Eur J Clin Microbiol Infect Dis 2001; 20:576.</a></li><li><a class="nounderline abstract_t">Falasca GF, Reginato AJ. The spectrum of myositis and rhabdomyolysis associated with bacterial infection. J Rheumatol 1994; 21:1932.</a></li><li><a class="nounderline abstract_t">Lawn SD, Bicanic TA, Macallan DC. Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS. Clin Infect Dis 2004; 38:461.</a></li><li><a class="nounderline abstract_t">Knees M, Ayub MT, Manikkan A. Gram-Negative Pyomyositis in an Immunocompetent Patient. Cureus 2018; 10:e2453.</a></li><li><a class="nounderline abstract_t">Whittier WL. Percutaneous kidney biopsy: "the needle and the damage done"? Am J Kidney Dis 2011; 57:808.</a></li><li><a class="nounderline abstract_t">Barakat MT, Gajurel K, Fischer K, et al. A Case of Meningococcal Pyomyositis in an Otherwise Healthy Adult. Open Forum Infect Dis 2016.</a></li><li><a class="nounderline abstract_t">Jensen M. Neisseria gonorrhoeae pyomyositis complicated by compartment syndrome: A rare manifestation of disseminated gonococcal infection. IDCases 2021; 23:e00985.</a></li><li><a class="nounderline abstract_t">Chu CK, Yang TL, Tan CT. Tuberculous pyomyositis of the temporal muscle in a nonimmunocompromised woman: diagnosis by sonography. J Laryngol Otol 2004; 118:59.</a></li><li><a class="nounderline abstract_t">Wang JY, Lee LN, Hsueh PR, et al. Tuberculous myositis: a rare but existing clinical entity. Rheumatology (Oxford) 2003; 42:836.</a></li><li><a class="nounderline abstract_t">Ahmed J, Homans J. Tuberculosis pyomyosits of the soleus muscle in a fifteen-year-old boy. Pediatr Infect Dis J 2002; 21:1169.</a></li><li><a class="nounderline abstract_t">Johnson DW, Herzig KA. Isolated tuberculous pyomyositis in a renal transplant patient. Nephrol Dial Transplant 2000; 15:743.</a></li><li><a class="nounderline abstract_t">Shih JY, Hsueh PR, Chang YL, et al. Pyomyositis due to Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use. Clin Infect Dis 1998; 26:505.</a></li><li><a class="nounderline abstract_t">Bertrand SL, Lincoln ED, Prohaska MG. Primary pyomyositis of the pelvis in children: a retrospective review of 8 cases. Orthopedics 2011; 34:e832.</a></li><li><a class="nounderline abstract_t">Niamane R, Jalal O, El Ghazi M, et al. Multifocal pyomyositis in an immunocompetent patient. Joint Bone Spine 2004; 71:595.</a></li><li><a class="nounderline abstract_t">Peckett WR, Butler-Manuel A, Apthorp LA. Pyomyositis of the iliacus muscle in a child. J Bone Joint Surg Br 2001; 83:103.</a></li><li><a class="nounderline abstract_t">Vij N, Ranade AS, Kang P, Belthur MV. Primary Bacterial Pyomyositis in Children: A Systematic Review. J Pediatr Orthop 2021; 41:e849.</a></li><li><a class="nounderline abstract_t">Shepherd JJ. Tropical myositis: is it an entity and what is its cause? Lancet 1983; 2:1240.</a></li><li><a class="nounderline abstract_t">Gonzalez Moran G, Garcia Duran C, Albiñana J. Imaging on pelvic pyomyositis in children related to pathogenesis. J Child Orthop 2009; 3:479.</a></li><li><a class="nounderline abstract_t">Meena AK, Rajashekar S, Reddy JJ, et al. Pyomyositis - clinical and MRI characteristics report of three cases. Neurol India 1999; 47:324.</a></li><li><a class="nounderline abstract_t">Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 43:953.</a></li><li><a class="nounderline abstract_t">Fountoukis T, Tsatsanidis N, Tilkeridou M, et al. Abdominal rectus muscle pyomyositis: Report of a case and review of the literature. Infect Dis Rep 2018; 10:7522.</a></li><li><a class="nounderline abstract_t">Watkins R, Vyas H. Toxic shock syndrome and streptococcal myositis: three case reports. Eur J Pediatr 2002; 161:497.</a></li><li><a class="nounderline abstract_t">Feigenberg T, Sela HY, Applbaum YH, Mankuta D. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome. Isr Med Assoc J 2008; 10:483.</a></li><li><a class="nounderline abstract_t">Harrington P, Scott B, Chetcuti P. Multifocal streptococcal pyomyositis complicated by acute compartment syndrome: case report. J Pediatr Orthop B 2001; 10:120.</a></li><li><a class="nounderline abstract_t">Aynaci O, Onder C, Kalaycioglu A. Anterior tibial compartment syndrome due to the pyomyositis in a patient with rheumatoid arthritis. A case report. Joint Bone Spine 2003; 70:77.</a></li><li><a class="nounderline abstract_t">Cone LA, Lamb RB, Graff-Radford A, et al. Pyomyositis of the anterior tibial compartment. Clin Infect Dis 1997; 25:146.</a></li><li><a class="nounderline abstract_t">Lin MY, Rezai K, Schwartz DN. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2008; 46:1553.</a></li><li><a class="nounderline abstract_t">Mantilla-Flórez YF, Echeverry-Díaz T, de la Espriella LD, Tuta-Quintero EA. Septic emboli from pyomyositis. Trop Doct 2020; 50:375.</a></li><li><a class="nounderline abstract_t">Yuksel H, Yilmaz O, Orguc S, et al. A pediatric case of pyomyositis presenting with septic pulmonary emboli. Joint Bone Spine 2007; 74:491.</a></li><li><a class="nounderline abstract_t">Chaudhary D, Aggarwal T, Pannu AK. Staphylococcus aureus pyomyositis and septic lung emboli. CMAJ 2022; 194:E126.</a></li><li class="breakAll">Chowdhury J, Sheth V, Patel K, et al. 1757: Pyomyositis resulting in septic pulmonary emboli: a rare presentation. Crit Care Med 2016; 44 (12): 514.</li><li><a class="nounderline abstract_t">Savvidou S, Kalogiannis E, Tsakiri K, et al. Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection? Braz J Infect Dis 2014; 18:457.</a></li><li class="breakAll">Wang S, Yeh T, Chang S, et al. Pelvic primary pyomyositis complicated by septic pulmonary embolism and shock in a young adult. J Med Sciences 2014; 34 (2): 88-90.</li><li><a class="nounderline abstract_t">Theodorou SJ, Theodorou DJ, Resnick D. MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases. Emerg Radiol 2007; 14:89.</a></li><li><a class="nounderline abstract_t">Mitsionis GI, Manoudis GN, Lykissas MG, et al. Pyomyositis in children: early diagnosis and treatment. J Pediatr Surg 2009; 44:2173.</a></li><li><a class="nounderline abstract_t">Soler R, Rodríguez E, Aguilera C, Fernández R. Magnetic resonance imaging of pyomyositis in 43 cases. Eur J Radiol 2000; 35:59.</a></li><li><a class="nounderline abstract_t">Kwak YG, Choi SH, Kim T, et al. Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection. Infect Chemother 2017; 49:301.</a></li><li><a class="nounderline abstract_t">Quillin SP, McAlister WH. Rapidly progressive pyomyositis. Diagnosis by repeat sonography. J Ultrasound Med 1991; 10:181.</a></li><li><a class="nounderline abstract_t">Tichter A, Riley DC. Emergency department diagnosis of a quadriceps intramuscular loculated abscess/pyomyositis using dynamic compression bedside ultrasonography. Crit Ultrasound J 2013; 5:3.</a></li><li><a class="nounderline abstract_t">Agarwal V, Chauhan S, Gupta RK. Pyomyositis. Neuroimaging Clin N Am 2011; 21:975.</a></li><li><a class="nounderline abstract_t">Levitt DL, Byer R, Miller AF. Point-of-Care Ultrasound to Diagnose Pyomyositis in a Child. Pediatr Emerg Care 2019; 35:69.</a></li><li><a class="nounderline abstract_t">Struk DW, Munk PL, Lee MJ, et al. Imaging of soft tissue infections. Radiol Clin North Am 2001; 39:277.</a></li><li><a class="nounderline abstract_t">Radcliffe C, Gisriel S, Niu YS, et al. Pyomyositis and Infectious Myositis: A Comprehensive, Single-Center Retrospective Study. Open Forum Infect Dis 2021; 8:ofab098.</a></li><li><a class="nounderline abstract_t">Sharma A, Kumar S, Wanchu A, et al. Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol 2010; 29:45.</a></li><li><a class="nounderline abstract_t">Hall RL, Callaghan JJ, Moloney E, et al. Pyomyositis in a temperate climate. Presentation, diagnosis, and treatment. J Bone Joint Surg Am 1990; 72:1240.</a></li></ol></div><div id="topicVersionRevision">Topic 7669 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24947530" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19013093" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Primary pyomyositis in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15380499" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Bacterial pyomyositis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12473721" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Primary pyomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15138315" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Tropical pyomyositis (myositis tropicans): current perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5722778" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pyomyositis tropicans in Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24983716" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Increasing pyomyositis presentations among children in Queensland, Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32147332" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pyomyositis in the United States 2002-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28003031" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pyomyositis is not only a tropical pathology: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15942515" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pyomyositis: a fatal case in a healthy teenager.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29274860" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Primary pyomyositis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5539187" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : “Tropical”pyomyositis. An unusual infection due to staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26879741" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pyomyositis in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1420680" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pyomyositis in North America: case reports and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11055607" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Pyomyositis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19340425" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Tropical primary pyomyositis in children of the UK: an emerging medical challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35626862" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pelvic Pyomyositis in Childhood: Clinical and Radiological Findings in a Tertiary Pediatric Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29289987" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pelvic pyomyositis in children: changing trends in occurrence and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23407284" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Tropical pyomyositis in children: 10 years experience of a tertiary care hospital in northern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1566321" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Tropical pyomyositis in eastern Ecuador.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10088678" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pyomyositis in children and adolescents: report of 12 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1867238" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pyomyositis in patients with the human immunodeficiency virus: an unusual form of disseminated bacterial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14653488" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pyomyositis in a 69-year-old tennis player.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9455539" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Proteus pyomyositis of the piriformis muscle in a swimmer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756817" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pyomyositis caused by vigorous exercise in a boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12931815" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Primary obturator pyomyositis: a diagnostic challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11086758" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Staphylococcus aureus thigh pyomyositis in a collegiate swimmer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7722819" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pyomyositis in an adolescent female athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10028081" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Obturator internus muscle abscess in children: report of seven cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16474970" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acute pyomyositis of the pelvis: the spectrum of clinical presentations and MR findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31467743" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Primary Pyomyositis: Contact Sports as the Rare Risk Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31467743" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Primary Pyomyositis: Contact Sports as the Rare Risk Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8478386" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Pyomyositis in patients who have the human immunodeficiency virus. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8665386" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : High HIV seroprevalence among patients with pyomyositis in northern Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2205925" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pyomyositis and human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7728875" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Viral infections: musculoskeletal infection in the human immunodeficiency virus (HIV) infected patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9402078" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12884066" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34407271" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Factors associated with pyomyositis: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35991747" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pyomyositis presenting as myonecrosis secondary to methicillin-resistant Staphylococcus aureus bacteremia in chronic lymphocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297743" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Tropical and temperate pyomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1674197" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7939725" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Nontropical pyomyositis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7942986" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Case report: diabetes mellitus as a predisposing factor in the development of pyomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8722950" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12371123" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Skin and soft tissue infections in injection drug users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10841689" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pyomyositis complicating acute bacterial endocarditis in an intravenous drug user.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12748161" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Temperate pyomyositis in an injecting drug misuser. A difficult diagnosis in a difficult patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11020398" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Tropical pyomyositis and human toxocariasis: a clinical and experimental study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11090021" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Nontropical pyomyositis: analysis of eight patients in an urban center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24755835" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19661356" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21297556" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Pyomyositis after chemotherapy for endometrial cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17723316" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pyomyositis associated with hematological malignancy: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35991590" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35982814" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on 18F-FDG PET-CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33290294" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Pseudomonas aeruginosa Pyomyositis in a Child With Acute Lymphoblastic Leukemia: A Case Report and Review of Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32107179" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : How long should we treat Candida albicans pyomyositis? Insight from a cured case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30911428" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pyomyositis in a Patient with IgA Nephropathy and Kidney Transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29660056" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Pyomyositis: an unusual cause of hip pain in a patient on certolizumab pegol and leflunomide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29419450" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28063458" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Thigh pyomyositis caused by group A streptococcus in an immunocompetent adult without any cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20038242" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414537" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Piriformis pyomyositis with sciatica: an unrecognized complication of "unsafe" abortions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35863859" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Unprovoked piriformis myositis presenting in a pregnant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7743579" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Piriformis pyomyositis mimicking epidural abscess in a parturient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19126914" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Piriformis pyomyositis: a report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22082187" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Piriformis pyomyositis, an unusual presentation of leg pain post partum--case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31049761" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Piriformis pyomyositis, a cause of piriformis syndrome-a systematic search and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/426186" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pyomyositis. Review of 205 cases in 112 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15295218" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15814887" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Pyomyositis caused by methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18327628" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Increased oxacillin resistance in thigh pyomyositis in diabetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16388041" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11681439" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Two cases of pyomyositis caused by Klebsiella pneumoniae and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7837162" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The spectrum of myositis and rhabdomyolysis associated with bacterial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14727228" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29888157" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Gram-Negative Pyomyositis in an Immunocompetent Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21601125" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Percutaneous kidney biopsy: "the needle and the damage done"?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : A Case of Meningococcal Pyomyositis in an Otherwise Healthy Adult</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33294370" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Neisseria gonorrhoeae pyomyositis complicated by compartment syndrome: A rare manifestation of disseminated gonococcal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14979977" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Tuberculous pyomyositis of the temporal muscle in a nonimmunocompromised woman: diagnosis by sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12826705" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Tuberculous myositis: a rare but existing clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12506952" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Tuberculosis pyomyosits of the soleus muscle in a fifteen-year-old boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10809836" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Isolated tuberculous pyomyositis in a renal transplant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9502485" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Pyomyositis due to Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22146198" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Primary pyomyositis of the pelvis in children: a retrospective review of 8 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15589449" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Multifocal pyomyositis in an immunocompetent patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11245514" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Pyomyositis of the iliacus muscle in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34411048" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Primary Bacterial Pyomyositis in Children: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6139580" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Tropical myositis: is it an entity and what is its cause?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19806379" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Imaging on pelvic pyomyositis in children related to pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10625910" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pyomyositis - clinical and MRI characteristics report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16983604" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29721242" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Abdominal rectus muscle pyomyositis: Report of a case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12200610" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Toxic shock syndrome and streptococcal myositis: three case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18669156" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11360777" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Multifocal streptococcal pyomyositis complicated by acute compartment syndrome: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12639625" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Anterior tibial compartment syndrome due to the pyomyositis in a patient with rheumatoid arthritis. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9243048" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Pyomyositis of the anterior tibial compartment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234871" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32623976" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Septic emboli from pyomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17703980" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : A pediatric case of pyomyositis presenting with septic pulmonary emboli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35101872" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Staphylococcus aureus pyomyositis and septic lung emboli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35101872" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Staphylococcus aureus pyomyositis and septic lung emboli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24794885" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24794885" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17333082" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19944229" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Pyomyositis in children: early diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10930768" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Magnetic resonance imaging of pyomyositis in 43 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29299899" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2027193" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Rapidly progressive pyomyositis. Diagnosis by repeat sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23402374" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Emergency department diagnosis of a quadriceps intramuscular loculated abscess/pyomyositis using dynamic compression bedside ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22032510" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Pyomyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30608330" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Point-of-Care Ultrasound to Diagnose Pyomyositis in a Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316360" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Imaging of soft tissue infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33884279" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Pyomyositis and Infectious Myositis: A Comprehensive, Single-Center Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19763666" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2398094" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Pyomyositis in a temperate climate. Presentation, diagnosis, and treatment.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
